Bio-Techne
TECH
#1880
Rank
NZ$19.70 B
Marketcap
NZ$125.86
Share price
0.42%
Change (1 day)
47.32%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): NZ$1.24

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$1.26. In 2025 the company made an earnings per share (EPS) of NZ$0.92 a decrease over its 2024 EPS that were of NZ$1.77.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.2434.35%
2025NZ$0.92-48%
2024NZ$1.77-29.58%
2023NZ$2.52-14.97%
2022NZ$2.9624.16%
2021NZ$2.3817.98%
2020NZ$2.02-10.94%
2019NZ$2.27101.57%
2018NZ$1.13-16.99%
2017NZ$1.3645.02%
2016NZ$0.94-20.97%
2015NZ$1.18-14.97%
2014NZ$1.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$32.30 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.68 669.01%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$14.52 1,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$9.20 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.65 190.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.37-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$10.83 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA